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1. Introduction 
While the biosynthetic pathway [l-4] as well as 
the catabolic metabolism via P-oxidation [3,5] has 
been firmly established for unsaturated fatty acids, 
the status of partial degradation is not nearly so clear. 
A great deal of evidence, both direct and indirect, has 
indicated that such a reaction might take place. As 
long as thirty ears ago, NUM and Smedley-MacLean 
[6] observed an increase of the amount of 
5.8.11.14.17-c20:s*, in fat deficient rats when 
4.7.10.13.16.19-C,:6 was added to the diet. During 
the last ten years other numerous experiments were 
described, indicating also chain-shortening with or 
without loss of a double bond [4,7-121. For example, 
in 1964 it was reported that in fat deficient rats, 
dietary 4.7.10.13.16~C,s :s was converted to 
58.11 .14CZOZ4 [8] . Some of these findings have been 
confirmed since then by metabolic studies with radio- 
actively labelled acids [ 13-171. On the other hand, 
careful studies [181 with specifically double-labelled 
9.12.octadecadienoic and 5.8.11.14-eicosatetraenoic 
acids revealed that these acids are either incorporated 
unchanged into complex lipids, or degraded complete- 
ly. Products of partial degradation could not be ob- 
served. 
In order to get some insight into the mechanism 
of partial degradation we have studied the metabolism 
of 4.7.10.13.16-C,,,, in subfractions of rat liver. 
* short-hand designation of fatty acids: 5.8.11.14.17-C2o:s i  
all&s-5.8.11.14.17eicosapentaenoic a id. 
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2. Experimenta 
4.7.10.13.16-C,, :s, 7.10.13.16-C22:4, and 
5.8.11 .14-Cze4 labelled with 3H, were synthesized 
as described previously [14, 191 . 
After esterification the crude acids were purified 
as methyl esters by chromatography on layers of 
silica gel H, 0.5 and 1 .O mm, impregnated with 20% 
silver nitrate. The solvent system used was heptane: 
ethyl acetate:acetone = 50:30:20. The same solvent 
system was applied when the total methyl esters of 
one incubation had to be separated according to their 
degree of unsaturation. The purified methyl esters were 
hydrolysed with 0.2 N methanolic KOH and subse- 
quently mixed with twice the equivalent of 0.1 N 
N&OH to obtain the ammonium salts. The animals 
used in these experiments were adult Wistar rats each 
weighing 200 f 15 g. They were provided with a 
normal diet ad libifum. ‘Ihe animals were killed by 
decapitation. 
Subcellular fractions of rat liver were prepared 
essentially according to the procedure of Schneider 
[20] with the modification of Bygrave [2 l] . 
Protein was measured by the biuret method as 
described by Beisenherz [22] . 
Glucose-6-phosphatase [23] and succinat-dehy- 
drogenase [24] were used as marker enzymes for the 
microsomal nd the mitochondrial fractions, respec- 
tively . 
Gas chromatographic analyses were carried out on 
a Hewlett-Packard Gas Chromatograph, Model 5750. 
The glass column used was 6 feet long, l/8 inch I.D., 
packed with 6% DEGS on Diatoport S, SO/l00 mesh. 
Radioactive methyl esters were trapped after gas 
chromatography in 10 ml scintillator solution (4 g 
2,5-diphenyl-oxazol and 0.5 g 1.4-bis-2(-4-methyl-5- 
North-Holland Publishing Company - Amsterdam 
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phenyloxazolyl)-benzene i  1 1 toluene) and counted 
in a liquid scintillation spectrometer, Packard Model 
3380. Unless otherwise stated each incubation con- 
tained the following: 0.5 mole radioactive fatty acid 
as ammonium salt, 1 mole coenzyme A, 10 wale 
ATP, 10 pmole MgClz , 1 pmole NAD+, 1 pmole NADH, 
1 mole NADPH, lO/..mole D,L-carnitin, 500 pmole 
potassium phosphate buffer (pH = 7.4,0.2 M) and 10 
mg protein of the subcellular f actions. The incuba- 
tions were carried out under nitrogen at 37” and 
stopped after the appropriate time by adding 2 N 
NaOH. The total fatty acids of each incubation were 
separated as methyl esters and subjected to gas 
chromatography. 
3. Results 
Incubation of 4.7.10.13.16~C.,,:s with various ub- 
cellular fractions of rat liver showed that the enzyme 
activity for partial degradation is entirely associated 
with the mitochondrial fraction. Less than 2% of the 
acitivity of 4.7.10.13.16-C,,:5 was found in 
5.8.11.14-C,,:, , or any other fatty acid, if the incuba- 
tion was carried out with the microsomal fraction or 
the 110,000 X g supernatant. In the mitochondrial 
fraction, however, two radioactive acids were found 
in addition to the added 4.7.10.13.16~Cs,,s. 
After separating the methyl esters according to the 
degree of unsaturation, these two radioactive acids 
were found to be present in the tetraen-fraction. 
Hydrogenation of this fraction afforded radioactive 
docosanoic acid as well as eicosanoic acid, indicating 
that the original acids had been docosa- and eicosa- 
tetraenoic acids. Gas chromatography proved these 
acids to be identical with authentic 7.10.13.16-docosa- 
tetraenoic and 5.8.11.14eicosatetranoic acids. . 
Between 60 and 90% of the radioactivity added to. 
each incubation mixture was recovered with the methyl 
ester fraction. When incubation times were increased 
the absolute activity of 4.7.10.13.16-Cz2:s decreased 
whereas the absolute activities of 7.10.13.16-C,,:, 
and 5.8.1 1.14-Czo:4 increased (table 1). The specific 
activities of the acids, however, showed markedly dif- 
ferent behaviour. These were of the same order to
magnitude and remained constant for 
4.7.10.13.16J&s and 7.10.13.16-C22:4, whereas the . . . . specrfrc actrvrty of 5.8.1 1.14.CzoZ4 were lower and in- 
creased with longer incubation times. Incubation of 
7.10.13.16~Css:, with the mitochondrial fraction 
gave rise to 5.8.11.14-C,,,, as the only partial degrada- 
tion product. If other subcellular f actions were used, 
chain shortening did not take place. 
When 5.8.11.14~Cae:,, was the incubated acid 
partial degradation did not occur at all. 
4. Discussion 
The results of these studies not only verify the 
partial degradation of 4.7.10.13.16-Cai:s to- 
5.8.11 .14-Cc2e:4 in vitro, but also reveal some d tails 
of the mechanism that could not be elucidated by in 
vivo experiments. From the‘theoretical point of view 
one could consider first a chain shortening and sub- 
sequently the loss of a double bond or the reverse. 
This means that either 2.5.8.11.14-C,:, or 
7.10.13.16cs,:, should be the intermediate. Schlenk, 
Gellermann and Sand postulated the existence of the 
former acid [ 131. 
Table 1 
Absolute and specific activities of 4.7.10.13.16-C rr:s, 7.10.13.16C22,4 and5.8.11.14C22,4 atdifferent incubationperiods. 
30 min 60 mm 90 mm 120 min 180 min 
4.7.10.13.16-C22,5 13,400c 48i4 8950 45i6 8450 43t3 7700 44*4 5300 45*6 
7.10.13.16-C22,4 900 45*5 2085 42*3 2800 4oi4 2800 4oi5 3250 43*5 
5.8.11.14C20:4 750 3.5t0.3 1940 8.6i0.4 2900 10.3io.3 3500 11.5*0.4 4420 14.5kO.8 
a Absolute activity of individual peak in one gas chromatogram. 
b Specific activity of individual methyl ester expressed as absolute activity of one peak divided by the peak area. 
c Values are the mean of three different incubations. 
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Our experiments indicate that the retroconversion 
of 4.7.10.13.16-C,,,, takes place in rat liver only in 
mitochondria, not on the endoplasmic reticulum or in 
the cytoplasm. Moreover, they show that 
7.10.13.16-C,,,, not 2.5.8.11.14-C,,,:, is a second 
partial degradation product besides 5.8.11.14-C,,,, 
The comparison of the specific activities (table 1) 
proves that 7.10.13.16-C2a,4 is the intermediate and 
5.8.1 1.14-C20:4 the end product. This reveals that 
initially the loss of the double bond, and subsequently 
the chain shortening, should be considered. 
Both the observed chain shortening of 
7.10.13.16+Ca2:, to 5.8.11 .14-C,0:4 in mitochondria, 
and the fact that 5.8.1 I .14-CZ0:4 is neither partially 
degraded nor elongated under the same incubation 
conditions, are in accord with this sequence of events. 
Similar findings too have recently been reported by 
Stoffel et al. [ 171 
How the two reactions proceed is unsolved at the 
moment. The simplest explanation for the first step 
would be a direct hydrogenation. But up to now only one 
mitochondrial enoyl-CoA-reductase has been described 
[25-271 . This enzyme with a chain length optimum 
at C6 reduces a&trans-enoyl-CoA esters. 
It is not known whether a cis double bond at 
position 4 of an acid with 22 carbon atoms is also 
hydrogenated by the same enzyme. 
The second step is not due to the reversal of the 
microsomal chain elongation sequence, but might 
rather be catalysed by the enzymes of P-oxidation. The 
enzyme activities responsible for chain shortening of 
7.10.13.16-C22:4 have been shown to be closely as- 
sociated with the enzyme activities of the P-oxidation 
cycle [17]. 
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